About Us

Nebulabio is a premier biotechnology Contract Research Organization (CRO) specializing in innovative antibody discovery solutions, with the Premade Phage scFv Library platform at the core of our success. With over 15 years of dedicated experience in phage display technology and library science, we have built one of the industry's most comprehensive collections of pre-validated, single-chain variable fragment (scFv) libraries. Our platform serves pharmaceutical companies, academic research institutions, and diagnostic developers worldwide, providing an immediate, reliable path to high-affinity antibody leads without the delays of custom library construction. Our team of molecular biologists, protein engineers, and bioinformaticians has successfully applied these libraries to discover therapeutic candidates against a vast array of challenging targets, including GPCRs, ion channels, viral antigens, and cancer biomarkers. We are committed to delivering not just a library, but a complete, performance-guaranteed discovery tool that accelerates your project from target to lead.

☞Introduction to Phage scFv Library Technology

The Phage scFv Library is a cornerstone of modern in vitro antibody discovery. An scFv (single-chain variable fragment) is an engineered antibody format where the variable domains of the heavy (VH) and light (VL) chains are connected by a short, flexible peptide linker, creating a single polypeptide that retains the full antigen-binding function of the parent antibody.

In our phage display system, the gene encoding the scFv is fused to a gene of a bacteriophage coat protein (most commonly the minor coat protein pIII of the M13 phage). When the engineered phage infects its bacterial host, the scFv-pIII fusion protein is expressed and incorporated onto the surface of the newly assembled phage particle. Crucially, the phage particle simultaneously packages the DNA encoding that specific scFv inside its capsid. This creates a direct and selectable link between the phenotype (the displayed scFv's binding function) and the genotype (its DNA sequence).

This linkage enables the powerful selection process called biopanning. A diverse library of scFv-displaying phages—containing billions of unique clones—is incubated with an immobilized target antigen. Non-binders are washed away, and specifically bound phages are eluted, amplified in E. coli, and put through repeated rounds of selection. This iterative process enriches the population for phages displaying the highest-affinity scFvs, allowing for the rapid isolation of lead candidates directly from the library.

☞Advantages of Our Premade Phage scFv Libraries

Choosing our Premade scFv Libraries provides a decisive strategic advantage, offering speed, reliability, and unparalleled value.

• Unmatched Speed to Screening: Eliminate the 3-4 months typically required for immunizations, RNA extraction, PCR amplification, and primary library construction. With a premade library, your screening campaign can begin immediately upon project initiation, compressing the overall discovery timeline.

• Proven Performance & Guaranteed Quality: Every premade library in our portfolio is subjected to rigorous Quality Control (QC). We provide a Certificate of Analysis detailing the library's physical titer (>10¹⁰ individual clones), functional diversity (via Next-Generation Sequencing), and panning performance against benchmark antigens. You start with a validated, high-performance reagent, not an experimental construct.

• Cost-Effectiveness and Accessibility: The significant investment in creating a large, high-diversity scFv library is distributed across multiple users. This makes world-class antibody discovery accessible for individual research projects and provides exceptional value for large-scale screening campaigns against multiple targets.

• Access to Unrivaled Diversity: Our libraries are constructed from very large, ethically sourced human donor pools or through sophisticated synthetic design, achieving diversities that are logistically and financially prohibitive for single custom projects. This maximizes your chances of finding rare, high-quality binders.

• Optimized for the scFv Format: Our libraries are cloned into vectors and produced under conditions specifically optimized for scFv expression and phage display. This ensures a high percentage of clones display full-length, well-folded proteins, leading to higher screening hit rates.

• Ideal for Challenging Targets & Innovative Formats: The scFv's small size and single-gene nature make it perfect for discovering binders to sterically restricted epitopes and for downstream engineering into bispecifics, CAR-T targeting domains, antibody-drug conjugates (ADCs), and intracellular antibodies (intrabodies).

☞Classification of scFv Libraries

Our portfolio is strategically categorized to meet diverse project requirements. Selection is based on the source of diversity and the design strategy.

 By Source of Diversity: 

• Naïve scFv Libraries: Derived from the natural, unimmunized B-cell repertoires of healthy human donors. These libraries offer broad, unbiased diversity against any conceivable antigen and are the universal starting point for novel target discovery.

• Immune scFv Libraries: Generated from humans or animals immunized with a specific antigen, pathogen, or cell line. These libraries are pre-enriched for specificity and often higher affinity, providing a faster route to leads against the target class of interest.

• Synthetic scFv Libraries: Built de novo by grafting designed diversity into the Complementarity-Determining Regions (CDRs) of one or more optimized human framework regions. These libraries offer fully humanized content from the start and allow for control over chemical diversity and developability profiles.

 By Design Strategy: 

• Universal Naïve Libraries: Large libraries (e.g., 10¹⁰+ clones) designed for maximum generic diversity.

• Target-Class Focused Libraries: Libraries built with immune repertoires against common target classes like GPCR peptides, kinase domains, or viral glycoproteins.

• Humanized & Stability-Optimized Libraries: Synthetic libraries designed on super-stable frameworks with humanized CDRs to yield leads with exceptional biophysical properties.

☞Phage scFv Library Construction Process

The high quality of our premade libraries is the result of a meticulous, multi-stage construction and validation pipeline.

 Phase 1: Repertoire Sourcing & Gene Amplification 

• For naïve libraries, B-cells are isolated from a large cohort of donors. For immune libraries, lymphocytes are harvested post-immunization.

• Total RNA is extracted and reverse transcribed into cDNA.

• VH and VL genes are amplified separately using family-specific primers or primers designed to capture the full repertoire.

 Phase 2: scFv Assembly & Library Cloning 

• Linker Insertion & Assembly: The VH and VL gene pools are spliced together via splicing by overlap extension (SOE) PCR, incorporating a flexible (Gly₄Ser)₃ linker between them to form the full scFv gene pool.

• Vector Ligation: The pooled scFv fragments are digested and ligated into a phagemid display vector (e.g., derived from pComb3X) upstream of the gene III sequence.

• Electroporation: The ligated DNA is purified and introduced into electrocompetent E. coli cells via high-voltage electroporation. This is a critical step to maximize transformation efficiency and achieve the highest possible library size.

 Phase 3: Primary Library Creation & QC 

• The transformed cells are grown and saved as a master bacterial glycerol stock, which preserves the genetic diversity of the library.

• A sample is taken for rescue with helper phage to produce the scFv-displaying phage stock.

• Comprehensive QC is performed:

1. Titering: To determine the library size in colony-forming units (CFU).

2. Insert Rate Analysis: PCR screening of random colonies to ensure >90% contain a full scFv insert.

3. NGS Diversity Analysis: Deep sequencing to assess VH/VL family usage, CDR3 length distribution, and overall sequence complexity.

Figure1.Reformatting selected scFvs from common phage libraries.

☞Our Service Workflow

Engaging with our Premade scFv Library service provides a seamless, end-to-end experience managed by our expert team.

 Step 1: Project Consultation & Library Selection 

We discuss your target antigen, desired antibody properties, and project goals. Based on this, we recommend the optimal premade scFv library from our portfolio and agree on screening and validation parameters.

 Step 2: Antigen Preparation & Protocol Design 

You provide the purified antigen. Our scientists design a customized panning protocol, selecting the immobilization method (direct coating, biotin-streptavidin) and defining the wash stringency to balance yield and selectivity.

 Step 3: Immediate Screening Initiation 

Using the pre-qualified, ready-to-use phage library, we begin the biopanning campaign without delay. We typically perform 3-4 rounds of selection, monitoring enrichment after each round via polyclonal phage ELISA and providing progress updates.

 Step 4: High-Throughput Hit Identification 

Individual clones from the final enriched output are picked into 96-well plates. Each is screened for antigen binding using monoclonal phage ELISA. All positive clones are sequenced.

Step 5: Bioinformatics Analysis & Lead Selection 

Sequences are analyzed using our proprietary pipeline. We identify unique scFvs, cluster them into families based on CDR homology, and select a diverse panel of leads for soluble expression, avoiding redundant clones.

 Step 6: Soluble scFv Expression & Validation 

The scFv genes of selected leads are subcloned into an expression vector. Proteins are produced in E. coli, purified, and subjected to validation:

• Binding Confirmation: ELISA.

• Affinity Measurement: Biolayer Interferometry (Octet) for kinetic analysis.

• Specificity Profiling: Testing against related proteins to check for cross-reactivity.

 Step 7: Final Delivery & Reporting 

You receive a comprehensive project report, all sequence data, expression plasmids for lead scFvs, and purified protein samples (optional). We hold a final review to discuss results and potential next steps (e.g., affinity maturation, reformatting to IgG).

 Our Integrated Service Flowchart: 

Accelerate your project timeline and leverage proven diversity. Contact us to select the ideal premade library and launch your accelerated path to high-quality antibody leads.